Due to the COVID-19 crisis, the information below is subject to change,
in particular that concerning the teaching mode (presential, distance or in a comodal or hybrid format).
3 credits
22.5 h
Q2
Teacher(s)
Frédérick Raphaël; Frédérick Raphaël (compensates Lambert Didier); Lambert Didier; Muccioli Giulio (coordinator);
Language
French
Prerequisites
organic chemistry and medicinal chemistry
Main themes
The general theme is drug discovery / drug design. During this EU the students will approach one or more drug discovery / drug design methodologies of their choice through a work allowing the deepening of the chosen techniques / methods.
In addition, all students participating in the EU will have the opportunity to have an overview of these methods through the presentation of each student's work.
In a non-exhaustive way the students will have the opportunity to deepen, according to their interest, techniques allowing the identification of hits for a given target (high throughput screening; computer-aided design (de novo design), ...), hit-to-lead strategies (e.g. structure-activity relationships; docking; etc).
In addition, all students participating in the EU will have the opportunity to have an overview of these methods through the presentation of each student's work.
In a non-exhaustive way the students will have the opportunity to deepen, according to their interest, techniques allowing the identification of hits for a given target (high throughput screening; computer-aided design (de novo design), ...), hit-to-lead strategies (e.g. structure-activity relationships; docking; etc).
Aims
At the end of this learning unit, the student is able to : | |
1 |
|
Content
- Lipidomics applied to the discovery of novel targets
- Exploring the proteome looking for novel targets : the enzymes ' the receptors
-
Proteins as therapeutic target
- Determination of their 3D structure
- Role of protein's 3D models in drug design
- The interest of establishing structure-activity relationships in drug design
Faculty or entity
FARM